What is symbicort used for
Pro Research Analysisby 
Searched over 200M research papers
Symbicort: Uses and Benefits in Asthma and COPD Management
Symbicort for Asthma Treatment
Combination Therapy for Asthma Control
Symbicort is a combination inhaler containing budesonide, a corticosteroid, and formoterol, a long-acting β2-agonist (LABA). This combination is used to manage asthma by addressing both inflammation and bronchoconstriction. Budesonide reduces airway inflammation, while formoterol provides rapid and long-lasting bronchodilation Halpin2008Kuna2002.
Symbicort Maintenance and Reliever Therapy (SMART)
Symbicort SMART (Symbicort Maintenance and Reliever Therapy) is a unique approach for treating moderate-to-severe asthma. It allows patients to use a single inhaler for both maintenance and relief, simplifying the treatment regimen. This method has been shown to prolong the time to the first severe asthma exacerbation, reduce the rate of exacerbations, and maintain day-to-day asthma control with a lower corticosteroid load compared to higher fixed maintenance doses of combination inhalers Selroos2007Peters2009.
Efficacy in Acute Asthmatic Attacks
In acute exacerbations of mild to moderate asthma, Symbicort has been found to be as effective as nebulized salbutamol in improving oxygen saturation, peak expiratory flow rate (PEFR), and respiratory rate. This makes it a viable alternative for reliever medication in emergency settings .
Real-Life Usage and Overuse Concerns
A study in Korea examined the real-life usage patterns of Symbicort SMART and found that while the frequency of overuse was not high, certain groups such as younger patients, those with limited physical activity, and those with nocturnal symptoms were more prone to overuse. This highlights the need for targeted education to ensure proper use .
Symbicort for Chronic Obstructive Pulmonary Disease (COPD)
Clinical Advantages in COPD Management
Symbicort is also used in the management of COPD. It offers clinical advantages over using its monocomponents separately, providing better control of symptoms and reducing exacerbations at little or no extra cost .
Pharmacoeconomic Benefits
Cost-Effectiveness
Symbicort has been shown to be cost-effective in both asthma and COPD management. In asthma, it reduces total treatment costs compared to using separate inhalers for budesonide and formoterol. The SMART approach, in particular, has been associated with lower direct and indirect costs due to fewer exacerbations and reduced medication use Halpin2008Price2007.
Improved Quality of Life
Patients using Symbicort report improved quality of life due to better asthma control and fewer exacerbations. The convenience of a single inhaler also enhances adherence to treatment, further contributing to better health outcomes and cost savings Zetterstrm’2002Price2007.
Conclusion
Symbicort is a versatile and effective treatment option for both asthma and COPD. Its combination of budesonide and formoterol addresses multiple aspects of these respiratory conditions, providing both maintenance and relief. The SMART approach simplifies treatment regimens and improves patient outcomes, making Symbicort a valuable tool in respiratory disease management.
Sources and full results
Most relevant research papers on this topic